Literature DB >> 11122718

Poor compliance: the hidden risk factor.

J C LaRosa1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11122718     DOI： 10.1007/s11883-000-0086-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  14 in total

Review 1.  Compliance with cardiovascular disease prevention strategies: a review of the research.

Authors:  L E Burke; J M Dunbar-Jacob; M N Hill
Journal:  Ann Behav Med       Date:  1997

2.  Management of hyperlipidaemia after coronary revascularisation: follow up study.

Authors:  E Delacrétaz; P G Michalopoulos; J Ruiz; H Saner; B Meier
Journal:  BMJ       Date:  1998-05-16

Review 3.  Impact of medication nonadherence on coronary heart disease outcomes. A critical review.

Authors:  M M McDermott; B Schmitt; E Wallner
Journal:  Arch Intern Med       Date:  1997-09-22

4.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

Review 5.  Clinical misconceptions dispelled by epidemiological research.

Authors:  W B Kannel
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

Review 6.  Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

Authors:  S E Andrade; A M Walker; L K Gottlieb; N K Hollenberg; M A Testa; G M Saperia; R Platt
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

7.  Factors affecting patient compliance with antihyperlipidemic medications in an HMO population.

Authors:  J C Sung; M B Nichol; F Venturini; K L Bailey; J S McCombs; M Cody
Journal:  Am J Manag Care       Date:  1998-10       Impact factor: 2.229

8.  Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.

Authors:  T E Strandberg; S Lehto; K Pyörälä; A Kesäniemi; H Oksa
Journal:  Eur Heart J       Date:  1997-11       Impact factor: 29.983

9.  Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study.

Authors:  F J Nieto; J Alonso; L E Chambless; M Zhong; M Ceraso; F J Romm; L Cooper; A R Folsom; M Szklo
Journal:  Arch Intern Med       Date:  1995-04-10

10.  Prevention of coronary heart disease in clinical practice: a commentary on current treatment patterns in six European countries in relation to published recommendations.

Authors:  J Shepherd; M Pratt
Journal:  Cardiology       Date:  1996 Jan-Feb       Impact factor: 1.869
View more
  3 in total

1.  Does medication adherence lower Medicare spending among beneficiaries with diabetes?

Authors:  Bruce Stuart; Amy Davidoff; Ruth Lopert; Thomas Shaffer; J Samantha Shoemaker; Jennifer Lloyd
Journal:  Health Serv Res       Date:  2011-03-17       Impact factor: 3.402

Review 2.  Interventions to improve adherence to lipid lowering medication.

Authors:  A Schedlbauer; K Schroeder; T J Peters; T Fahey
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

3.  Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis.

Authors:  Jae Song Kim; Min Jung Geum; Eun Sun Son; Yun Mi Yu; Jae Hee Cheon; Kyeng Hee Kwon
Journal:  Gut Liver       Date:  2022-02-11       Impact factor: 4.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.